Lista de obras -

Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects

artículo científico publicado en 2007

AllerGen’s 8th research conference.

artículo científico publicado en 2016

Allergen immunotherapy on the way to product-based evaluation-a WAO statement

artículo científico publicado en 2015

Allergen immunotherapy with cat allergen peptides

artículo científico publicado en 2003

An Update on Lymphocyte Subtypes in Asthma and Airway Disease

artículo científico publicado en 2016

Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016.

artículo científico publicado en 2017

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

artículo científico publicado en 2018

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.

artículo científico publicado en 2011

Developmental T cell receptor gene rearrangements: relatedness of the alpha/beta and gamma/delta T cell precursor.

artículo científico publicado en 1991

Diversity of T-cell receptor alpha gene transcripts in the newborn and adult periphery

artículo científico publicado el 1 de enero de 1992

Environmental and allele-specific influences on T cell receptor gene rearrangement: skewed alpha, delta, and gamma gene rearrangement patterns in chimeric mice

artículo científico publicado en 1991

Environmental influence on T cell receptor alpha gene rearrangement and expression in vitro

artículo científico publicado el 1 de octubre de 1992

Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

artículo científico publicado en 2017

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

artículo científico publicado en 2012

Fetal thymocyte potential for T cell receptor V gamma 3-J gamma 1 junctional modification

scientific article published on 01 June 1993

Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre- and post-peptide immunotherapy: an open-label clinical study

artículo científico publicado en 2020

Immunological mechanisms of allergen-specific immunotherapy

artículo científico publicado en 2006

Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study.

artículo científico publicado en 2013

Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses

Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia

scientific article published on 18 December 2019

Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy

scientific article published on 12 June 2018

Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge.

artículo científico publicado en 2017

Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections

scientific article published in 2021

Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides

artículo científico publicado en 2003

Legends of allergy/immunology: A. Barry Kay

scientific article published on 02 June 2019

Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation.

artículo científico publicado en 2013

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy

scientific article published on 07 June 2019

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen

scientific article published on 10 March 2020

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression

artículo científico publicado en 2009

Peptide therapy and asthma

artículo científico publicado en 2004

Peptide-based immunotherapy: a novel strategy for allergic disease

artículo científico publicado en 2005

Peptide-based vaccines in the treatment of specific allergy

artículo científico publicado en 2002

Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012-2015.

artículo científico publicado en 2017

Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015

artículo científico publicado en 2016

Proliferation of Circulating T-Lymphocytes

artículo científico publicado el 1 de enero de 2000

Restricted usage of T-cell receptor V alpha sequence and variable-joining pairs after normal T-cell development and bone marrow transplantation

artículo científico publicado en 1993

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

artículo científico publicado en 2016

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

artículo científico publicado en 2005

The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

artículo científico publicado en 2018

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

artículo científico publicado en 2006

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

artículo científico publicado en 2013

The potential of peptide immunotherapy in allergy and asthma

artículo científico publicado en 2002

The role of T lymphocytes in the pathogenesis of asthma

artículo científico publicado en 2003

Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.

artículo científico publicado en 2017

Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes.

artículo científico publicado en 2013

T‐cell responses to house dust mites: bad news for immunotherapy? ⬇️

artículo científico publicado el 1 de agosto de 1997

Lista de obras de

Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects

AllerGen’s 8th research conference.

Allergen immunotherapy on the way to product-based evaluation-a WAO statement

Allergen immunotherapy with cat allergen peptides

An Update on Lymphocyte Subtypes in Asthma and Airway Disease

Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016.

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.

Developmental T cell receptor gene rearrangements: relatedness of the alpha/beta and gamma/delta T cell precursor.

Diversity of T-cell receptor alpha gene transcripts in the newborn and adult periphery

Environmental and allele-specific influences on T cell receptor gene rearrangement: skewed alpha, delta, and gamma gene rearrangement patterns in chimeric mice

Environmental influence on T cell receptor alpha gene rearrangement and expression in vitro

Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

Fetal thymocyte potential for T cell receptor V gamma 3-J gamma 1 junctional modification

Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre- and post-peptide immunotherapy: an open-label clinical study

Immunological mechanisms of allergen-specific immunotherapy

Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study.

Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses

Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia

Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy

Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge.

Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections

Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides

Legends of allergy/immunology: A. Barry Kay

Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation.

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression

Peptide therapy and asthma

Peptide-based immunotherapy: a novel strategy for allergic disease

Peptide-based vaccines in the treatment of specific allergy

Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012-2015.

Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015

Proliferation of Circulating T-Lymphocytes

Restricted usage of T-cell receptor V alpha sequence and variable-joining pairs after normal T-cell development and bone marrow transplantation

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

The potential of peptide immunotherapy in allergy and asthma

The role of T lymphocytes in the pathogenesis of asthma

Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.

Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes.

T‐cell responses to house dust mites: bad news for immunotherapy? ⬇️